Tea polyphenol protects against cisplatin-induced meiotic defects in porcine oocytes
Authors:
- 13 July 2019
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 11 (13) , 4706-4719
Abstract
DDP (cisplatin), a DNA cross-linking agent, is one of the most common chemotherapeutic drugs that have been widely used in the treatment of sarcomas and germ cell tumors. DDP treatment exhibits severe side effects including renal toxicity, ototoxicity and embryo-toxicity. Women of reproductive age treated with DDP may lead to loss of primordial follicles, resulting in the depletion of the ovarian reserve and consequent premature ovarian failure. However, the influence of DDP on the oocyte quality and the strategy to prevent it has not yet fully clarified. Here, we report that DDP exposure resulted in the oocyte meiotic failure via disrupting the meiotic organelle dynamics and arrangement, exhibiting a prominently impaired cytoskeleton assembly, including spindle formation and actin polymerization. In addition, exposure to DDP led to the abnormal distribution of mitochondrion and cortical granules, two indicators of cytoplasmic maturation of oocytes. Conversely, TP (tea polyphenols) supplementation partially restored all of the meiotic defects resulted from DDP exposure through suppressing the increase of ROS level and the occurrence of DNA damage as well as apoptosis.Keywords
This publication has 51 references indexed in Scilit:
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equationDrug Resistance Updates, 2016
- An integrated view of cisplatin-induced nephrotoxicity and ototoxicityToxicology Letters, 2015
- Cisplatin: an old drug with a newfound efficacy – from mechanisms of action to cytotoxicityExpert Opinion on Pharmacotherapy, 2013
- On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer ChemotherapyBioinorganic Chemistry and Applications, 2012
- Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal modelsEuropean Archives of Oto-Rhino-Laryngology, 2012
- DNA damage-induced cell death by apoptosisTrends in Molecular Medicine, 2006
- Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damageBiochemical and Biophysical Research Communications, 2006
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996